GENE ONLINE|News &
Opinion
Blog

Liver Cancer
AstraZeneca’s Liver Cancer Treatment Combination Snatches FDA Approval
2022-10-24
Merck and Eisai Come Up Short in the Clinic with Liver Cancer Combination Therapy
2022-08-04
Three Companies Received Orphan Drug Designations in One Day To Treat Rare Cancers
2022-06-20
China’s Hengrui Buds Off New Biotech With 11 Therapeutic Programs
2022-05-19
Ultrasound Transducer for Combined Histotripsy Breaks Down Cancer Tumors
2022-04-27
Shionogi, NEC Team Up on Hepatitis B Vaccine
2022-04-20
uniQure’s Inquiry Shows Hemophilia B Gene Therapy not Likely to Have Induced Liver Cancer
2021-03-30
uniQure’s Hemophilia B Gene Therapy Put on Clinical Hold by the FDA
2020-12-22
China’s Regulatory Body Accepts Application for First Selective Internal Radiation Therapy for HCC
2020-11-29
Weekly Cover : Fosun and BioNTech Invest USD 135m for Covid-19 Vaccine
2020-03-19
Roche’s Elecsys GALAD Score that Predicts HCC Occurrence, Bags Breakthrough Designation
2020-03-06
Singapore HSA approves phase I/II clinical trial for precision T-cell receptor immunotherapy
2018-09-14
LATEST
Healthcare+ Expo Taiwan 2024 To Become A Global Trade Fair With 600+ Companies Attending
2024-11-29
Cracking the Code: How Genetics Shapes Strength, Power, and Speed in Sports
2024-11-27
Shared Expertise, Shared Vision: Biotech Powerhouses Drive Innovation in This Billion-Dollar Market
2024-11-27
MIRDC Hosts Seminar Featuring Diverse Applications of Plasma Sterilization Technology
2024-11-26
How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando
2024-11-26
PuriBlood Breaks into Brazil: Partners with ABHH and Cromo to Conquer Latin America’s Largest Blood Market
2024-11-26
Merck’s Multi-Billion-Dollar KEYTRUDA Levels Up with Novel Subcutaneous Delivery, Matching IV Efficacy
2024-11-22
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
Scroll to Top